Despite advances in perioperative critical care and surgical technique, spinal cord ischemia remains a devastating complication of thoracic and thoracoabdominal aortic aneurysm repair. Biochemical markers present in peripheral blood and cerebrospinal fluid (CSF) may be useful in assessing spinal cord injury. We systematically analyze and report the role of all reported biochemical markers that have been used in assessing and diagnosing spinal cord ischemia in thoracic and thoracoabdominal aortic aneurysm repair.
Methods:
Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines were used for this review. Published literature was searched to identify all studies reporting on the use of biochemical markers in thoracoabdominal aortic aneurysm repair in the assessment of spinal cord ischemia. Marker-specific and patient-specific data were extracted from all studies and where possible, subgroup analysis was performed on marker-specific data sets.
Results:
Fourteen studies of 321 patients undergoing thoracic and thoracoabdominal aortic aneurysm repair were eligible for further analysis. Seven distinct biochemical markers were used in both CSF and blood samples: S100B proteins (S100B), neurone-specific enolase, lactate dehydrogenase, glial fibrillary acidic protein (GFAp), neurofilament triplet protein (NFL) and Tau protein, and glucose. There was substantial evidence demonstrating the heightened levels of S100, NFL, and GFAp in CSF in patients with spinal cord ischemia. There is however, wide variability in the correlation of the same 6 biochemical markers in peripheral blood and spinal cord ischemia.
Conclusions:
In patients with spinal cord injury, dramatic rises occur with S100B, NFL, and GFAp in CSF. However, further work is needed if biochemical markers are to impact on the future of thoracoabdominal aortic aneurysm repair.
WongDRParentiJLGreenSY. Open repair of thoracoabdominal aortic aneurysm in the modern surgical era: contemporary outcomes in 509 patients. J Am Coll Surg. 2011;212(4):569–579; discussion 79-81.
2.
ConradMFCrawfordRSDavisonJKCambriaRP. Thoracoabdominal aneurysm repair: a 20-year perspective. Ann Thorac Surg. 2007;83(2):S856–S861; discussion S90-2.
3.
BackesWHNijenhuisRJMessWHWilminkFASchurinkGWJacobsMJ. Magnetic resonance angiography of collateral blood supply to spinal cord in thoracic and thoracoabdominal aortic aneurysm patients. J Vasc Surg. 2008;48(2):261–271.
4.
TabayashiKSaikiYKokuboH. Protection from postischemic spinal cord injury by perfusion cooling of the epidural space during most or all of a descending thoracic or thoracoabdominal aneurysm repair. Gen Thorac Cardiovasc Surg. 2010;58(5):228–234.
5.
JacobsMJMessWMochtarBNijenhuisRJStatius van EpsRGSchurinkGW. The value of motor evoked potentials in reducing paraplegia during thoracoabdominal aneurysm repair. J Vasc Surg. 2006;43(2):239–246.
6.
KeyhaniKMillerCCIIIEstreraALWegrynTSheinbaumRSafiHJ. Analysis of motor and somatosensory evoked potentials during thoracic and thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2009;49(1):36–41.
BicknellCDCheshireNJRigaCV. Treatment of complex aneurysmal disease with fenestrated and branched stent grafts. Eur J Vasc Endovasc Surg. 2009;37(2):175–181.
9.
DrinkwaterSLGoebellsAHaydarA. The incidence of spinal cord ischaemia following thoracic and thoracoabdominal aortic endovascular intervention. Eur J Vasc Endovasc Surg. 2010;40(6):729–735.
10.
GreenbergRKLuQRoselliEE. Contemporary analysis of descending thoracic and thoracoabdominal aneurysm repair: a comparison of endovascular and open techniques. Circulation. 2008;118(8):808–817.
11.
EngLFVanderhaeghenJJBignamiAGerstlB. An acidic protein isolated from fibrous astrocytes. Brain Res. 1971;28(2):351–354.
12.
WeingartenMDLockwoodAHHwoSYKirschnerMW. A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A. 1975;72(5):1858–1862.
13.
MoherDLiberatiATetzlaffJAltmanDG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
14.
van DongenEPTer BeekHTBoezemanEHSchepensMALangemeijerHJAartsLP. Normal serum concentrations of S-100 protein and changes in cerebrospinal fluid concentrations of S-100 protein during and after thoracoabdominal aortic aneurysm surgery: Is S-100 protein a biochemical marker of clinical value in detecting spinal cord ischemia?J Vasc Surg. 1998;27(2):344–346.
15.
van DongenEPter BeekHTSchepensMA. The relationship between evoked potentials and measurements of S-100 protein in cerebrospinal fluid during and after thoracoabdominal aortic aneurysm surgery. J Vasc Surg. 1999;30(2):293–300.
16.
TeiIKohEYokoyamaS. Clinical study of serum S-100 beta protein as marker of brain injury in cardiovascular surgery [in Japanese]. Kyobu Geka. 1999;52(13):1090–1094.
17.
NagyGDzsinichCSepaG. New method for the intraoperative biochemical monitoring of cerebrospinal fluid in surgery of thoracoabdominal aortic aneurysms [in Hungarian]. Orv Hetil. 2000;141(24):1343–1347.
18.
AndersonREHanssonLOVaageJ. Release of S100B during coronary artery bypass grafting is reduced by off-pump surgery. Ann Thorac Surg. 1999;67(6):1721–1725.
19.
JonssonHJohnssonPAllingCBackstromMBerghCBlomquistS. S100beta after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychological outcome. Ann Thorac Surg. 1999;68(6):2202–2208.
20.
AndersonREHanssonLOLiskaJSettergrenGVaageJ. The effect of cardiotomy suction on the brain injury marker S100beta after cardiopulmonary bypass. Ann Thorac Surg. 2000;69(3):847–850.
21.
AndersonREHanssonLONilssonOLiskaJSettergrenGVaageJ. Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources. Ann Thorac Surg. 2001;71(5):1512–1517.
22.
VaageJAndersonR. Biochemical markers of neurologic injury in cardiac surgery: the rise and fall of S100beta. J Thorac Cardiovasc Surg. 2001;122(5):853–855.
23.
LeMaireSABhamaJKSchmittlingZC. S100beta correlates with neurologic complications after aortic operation using circulatory arrest. Ann Thorac Surg. 2001;71(6):1913–1918; discussion 8-9.
24.
BrunnekreefGBHeijmenRHGerritsenWBSchepensMAter BeekHTvan DongenEP. Measurements of cerebrospinal fluid concentrations of S100beta protein during and after thoracic endovascular stent grafting. Eur J Vasc Endovasc Surg. 2007;34(2):169–172.
25.
KuniharaTShiiyaNYasudaK. Changes in S100beta protein levels in cerebrospinal fluid after thoracoabdominal aortic operations. J Thorac Cardiovasc Surg. 2001;122(5):1019–1020.
26.
AndersonREWinnerkvistAHanssonLO. Biochemical markers of cerebrospinal ischemia after repair of aneurysms of the descending and thoracoabdominal aorta. J Cardiothorac Vasc Anesth. 2003;17(5):598–603.
27.
ShiiyaNKuniharaTMiyatakeTMatsuzakiKYasudaK. Tau protein in the cerebrospinal fluid is a marker of brain injury after aortic surgery. Ann Thorac Surg. 2004;77(6):2034–2038.
28.
LasesECSchepensMAHaasFJ. Clinical prospective study of biochemical markers and evoked potentials for identifying adverse neurological outcome after thoracic and thoracoabdominal aortic aneurysm surgery. Br J Anaesth. 2005;95(5):651–661.
29.
WinnerkvistAAndersonREHanssonLO. Multilevel somatosensory evoked potentials and cerebrospinal proteins: indicators of spinal cord injury in thoracoabdominal aortic aneurysm surgery. Eur J Cardiothorac Surg. 2007;31(4):637–642.
30.
KhaladjNTeebkenOEHaglC. The role of cerebrospinal fluid S100 and lactate to predict clinically evident spinal cord ischaemia in thoraco-abdominal aortic surgery. Eur J Vasc Endovasc Surg. 2008;36(1):11–19.
31.
MerissonEMattssonNZetterbergH. Total-tau and neurofilament light in CSF reflect spinal cord ischaemia after endovascular aortic repair. Neurochem Int. 2016;93:1–5.
32.
DrengerBParkerSDFrankSMBeattieC. Changes in cerebrospinal fluid pressure and lactate concentrations during thoracoabdominal aortic aneurysm surgery. Anesthesiology. 1997;86(1):41–47.
33.
HiramotoJSFernandezCGasperWVartanianSReillyLChuterT. Lower extremity weakness is associated with elevated blood and cerebrospinal fluid glucose levels following multibranched endovascular aortic aneurysm repair. J Vasc Surg. 2017;65(2):311–317.
GueritJMDionRA. State-of-the-art of neuromonitoring for prevention of immediate and delayed paraplegia in thoracic and thoracoabdominal aorta surgery. Ann Thorac Surg. 2002;74(5):S1867–S1869; discussion S92-8.
MaviliaCCouchieDMatteiMGNivezMPNunezJ. High and low molecular weight tau proteins are differentially expressed from a single gene. J Neurochem. 1993;61(3):1073–1081.
38.
BinderLIFrankfurterARebhunLI. The distribution of tau in the mammalian central nervous system. J Cell Biol. 1985;101(4):1371–1378.
